Trailing-twelve-month (TTM) revenue is $60.26 Million with a year-over-year growth of +3.26%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $14,316,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-06 |
| Q4 FY2025Period ended 2025-12-31 | $16,025,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-31 |
| Q1 FY2026Period ended 2026-03-31 | $13,428,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $16,495,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-13 |
| TTM revenue | $60,264,000 |
Current P/S: $82,348,001 market capitalization ÷ $60,264,000 TTM revenue = 1.37x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T15:15:10.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $16.50M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T15:17:36.529Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Product | $20M | $26M | $26M | $32M | $41M | $46M |
| Service | $3M | $3M | $3M | $4M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia Excluding South Korea | $4M | $4M | $4M | $4M | $5M | $8M |
| Europe | $4M | $6M | $4M | $6M |
$60.26M
$60.26 Million
+3.26%
vs. $58.36M a year ago (TTM)
+14.67%
5 Year compound annual growth rate
1 Year
+3.26%
3 Year
+16.36%
5 Year
+14.67%
10 Year
N/A
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $58.44M | +$4.94M | +9.24% |
| 2024 | $53.49M | +$11.33M | +26.87% |
| 2023 | $42.16M | +$6.81M | +19.25% |
| 2022 | $35.36M | +$899,000 | +2.61% |
| 2021 | $34.46M | +$8.08M | +30.62% |
| 2020 |
TTM Growth
+3.26%
3-Year CAGR
+16.36%
5-Year CAGR
+14.67%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 26 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T15:17:36.529Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $6M |
| $8M |
| KOREA, REPUBLIC OF | $3M | $4M | $2M | $257,000 | $848,000 | $658,000 |
|---|
| Other Geographical Region | $319,000 | $449,000 | $502,000 | $776,000 | $563,000 | $238,000 |
|---|
| UNITED STATES | $12M | $15M | $19M | $25M | $29M | $34M |
|---|
| $26.38M |
| ($4.15M) |
| (13.58%) |
| 2019 | $30.53M | +$6.14M | +25.18% |
